Initial Statement of Beneficial Ownership

This filing is an Initial Statement of Beneficial Ownership (Form 3) for Ryan Trasolini, Co-Chief Executive Officer of Shuttle Pharmaceuticals Holdings, Inc. (SHPH). The report indicates that Mr. Trasolini does not beneficially own any shares of the issuer as of May 6, 2026. The signature date is June 1, 2026.